预后不良患者晚成熟卵母细胞补救:延迟卵胞浆内单精子注射可获得更多可移植胚胎
该回顾性分析纳入250例预后不良患者的311个辅助生殖技术周期、2243枚卵母细胞,评估延迟卵胞浆内单精子注射(DICSI)对晚成熟卵母细胞的影响。结果显示,原评估为MI或MII的卵母细胞所形成囊胚的非整倍体率无差异,移植后活产率相似;DICSI使至少27个周期(8.7%)获得活产,另有5例持续妊娠。作者认为DICSI对预后不良患者有价值。
要点
- 原评估为MI与MII的卵母细胞所形成囊胚,非整倍体率无差异。
- 原评估为MI的成熟卵母细胞来源囊胚,移植后活产率与MII来源相似。
- DICSI使至少27个周期(8.7%)获得活产,另有5例持续妊娠。
核心结论
- MI和生发泡卵母细胞均可在体外完成成熟,其形成的囊胚染色体可能正常,活产率与MII来源相似。
- DICSI未改变分娩方式、妊娠期或出生体重,并提高整体辅助生殖技术周期成功率,作者认为该方法对预后不良患者有价值。
研究设计与样本
- 回顾性分析纳入250例预后不良患者的311个辅助生殖技术周期,共2243枚卵母细胞。
- 当第0天采集卵母细胞中超过50%未成熟、第1天注射卵母细胞受精率低于50%或患者进行胚胎植入前非整倍体遗传学检测时,向患者提供DICSI。
主要发现
- 受精率和囊胚形成率因卵母细胞成熟阶段原始评估不同而异。
- 原评估为MI或MII的卵母细胞所形成囊胚的非整倍体率无差异。
- 原评估为MI的成熟卵母细胞来源囊胚移植后活产可能性与MII来源相似。
- 卵胞浆内单精子注射与DICSI在分娩方式、妊娠期和出生体重方面无差异。
- DICSI使至少27个周期(8.7%)获得活产,另有5例持续妊娠。
临床怎么用
- 作者认为DICSI对预后不良患者有价值,可增加可用于检测的胚胎数量并提高整体辅助生殖技术周期成功率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can delayed intracytoplasmic sperm injection (DICSI) in late maturing oocytes improve fertilization, blastocyst formation, pregnancy and live birth rates for poor-prognosis patients? DESIGN: Retrospective analysis of 2243 oocytes from 250 poor-prognosis patients who underwent 311 assisted reproductive technology (ART) cycles. Patients were offered DICSI to increase the number of embryos available for testing when over 50% of oocytes collected were immature on day 0, less than 50% of the injected oocytes were fertilized on day 1 or when patients were undergoing preimplantation genetic testing for aneuploidy. RESULTS: Fertilization and blastulation rates differed depending on the original assessment of the oocyte maturation stage. Euploidy rate did not differ between blastocysts derived from fertilized oocytes originally assessed as metaphase I (MI) or metaphase II (MII). A transferred blastocyst derived from a matured oocyte originally assessed as MI was as likely to result in a live birth as one from a MII oocyte. No differences in delivery method, gestation period or birth weight were found between intracytoplasmic sperm injection and DICSI. As a result of DICSI, at least 27 cycles (8.7%), which would have otherwise been unproductive, resulted in live births, with five ongoing pregnancies. CONCLUSIONS: Both MI and germinal vesicle oocytes can complete maturation in vitro. Blastocysts produced from these are likely to be chromosomally normal compared with oocytes originally assessed as MII, and result in similar live birth rates. With no differences in birth outcomes, and DICSI increasing overall ART cycle success, this approach has value for poor-prognosis patients.
引用
- Hashimi BA, Harvey SC, Harvey KE, et al. Late maturing oocyte rescue in poor-prognosis patients: delayed intracytoplasmic sperm injection results in more viable embryos. Reprod Biomed Online. 2024. PMID: 40158338. doi:10.1016/j.rbmo.2024.104735
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。